Hannover, Germany

Andreas Zgraja

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andreas Zgraja

Introduction

Andreas Zgraja is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in gene transfer and peptide synthesis. With a total of 2 patents, Zgraja's work has the potential to impact various medical applications.

Latest Patents

Zgraja's latest patents include "Protransduzin B," which is a gene transfer enhancer. This patent describes an N-terminally protected peptide with a specific sequence, wherein X represents a group protecting the N-terminal of the peptide. Another significant patent is the "Process for preparing human relaxin-2," which outlines a method for producing human relaxin-2 with a defined amino acid sequence.

Career Highlights

Throughout his career, Zgraja has worked with several companies, including Relaxera Pharma GmbH & Co. KG and Pharis Biotec GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the biotechnology sector.

Collaborations

Zgraja has collaborated with notable professionals in his field, including Wolf-Georg Forssmann and Thomas Dschietzig. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Andreas Zgraja's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in gene transfer and peptide synthesis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…